Notch Therapeutics
PrivateLast Round
M&A
Apr 2, 2025
Est. Valuation
$20M
Total Funding Raised
$90M
Company Overview
Notch Therapeutics is a biotechnology company that develops renewable, induced pluripotent stem cell (iPSC)-derived immunotherapies for cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notch Therapeutics Comparables
Compare Notch Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shinobi Therapeutics, Inc. | 84% | |
| Shoreline Biosciences | 82% | |
| Rebirthel Co., Ltd. | 82% | |
Notch Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 2, 2025 | ||||
| Series A | Feb 10, 2021 | ||||
| Seed | Nov 1, 2019 |
Notch Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A |
| Amplitude Ventures | Series A |
| CCRM | Series A, Seed |
| CCRM Enterprises Inc. | Series A |
| Lumira Ventures | Seed, Series A |
| Casdin Capital | Series A |
| TIAP | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2025
Roche Holding led the M&A round.
- Nov 1, 2019
$5M round with participation from Lumira Ventures and TIAP.
Notch Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Notch Therapeutics's valuation, stock price, and market status.